# Uraemic Toxin Removal Principles > Uraemic toxin removal principles for Dialysis Technology: small, middle and protein-bound toxins, diffusion versus convection, membrane flux and clearance. - Canonical URL: https://prepelephant.com/topics/allied/dialysis-technology/uraemic-toxin-removal-principles - Exam / course: Allied Health · Subject: Dialysis Technology - Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team - First published: 2026-10-02 - Last updated: 2026-10-02 - How to cite: "Uraemic Toxin Removal Principles", PrepElephant, https://prepelephant.com/topics/allied/dialysis-technology/uraemic-toxin-removal-principles ## Direct answer Uraemic toxins sort into three groups by how they behave across a membrane: small solutes under about 500 daltons (urea 60, creatinine 113, potassium, uric acid) that diffuse rapidly; middle molecules of roughly 500-15,000 daltons (beta-2 microglobulin at 11,800) that need convective transport and porous high-flux membranes; and protein-bound solutes such as indoxyl sulphate and p-cresyl sulphate that neither dialysis mode removes efficiently. The dialyser clears them by diffusion down a concentration gradient, convection carried by water movement (ultrafiltration), and adsorption onto the membrane itself. Prescribing is the art of matching modality to toxin class — which is why low-flux dialysis controls urea but not amyloidosis. ## What you must remember - **Small solutes:** molecular weight under ~500 Da, water soluble, distributed in total body water; removed mainly by diffusion; the Kt/V target of at least 1.2 is a urea (60 Da) statement. - **Middle molecules:** 500-15,000 Da; beta-2 microglobulin (11,800 Da) accumulates as dialysis-related amyloidosis — carpal tunnel syndrome, arthropathy, cystic bone lesions — after years on low-flux dialysis. - **Protein-bound toxins:** indoxyl sulphate, p-cresyl sulphate (over 90 per cent albumin-bound); poorly cleared by any extracorporeal modality; implicated in itching, inflammation and cardiovascular damage. - **Diffusion** moves solute down its gradient and favours small molecules — increasing dialysate flow and surface area raises it; doubling blood flow matters less once the gradient flattens. - **Convection** drags solute across the membrane with water (solute drag) and clears middle molecules far better — the basis of haemofiltration, haemodiafiltration, and high-flux dialysis with backfiltration. - **Membrane terminology:** low-flux Kuf under about 10 mL/h/mmHg versus high-flux above 20; ultrafiltration coefficient defines how much water the membrane passes per hour per mmHg of transmembrane pressure. - **Adsorption** binds proteins and some toxins to the membrane surface — useful, but it also fouls the membrane and progressively drops clearance within a session. - **Clearance versus removal:** a dialyser may clear 200 mL/min of urea from blood yet remove only a fraction of total body urea — dose is Kt/V, not the clearance number on the box. ## Diffusion, convection, adsorption — one membrane, three jobs Take three patients and one membrane. The first, on thrice-weekly low-flux haemodialysis with excellent urea clearances, develops burning shoulder pain and carpal tunnel compression after eight years: beta-2 microglobulin, a middle molecule, has been depositing as amyloid because diffusion barely touches an 11,800-dalton sphere. The prescription changes to a high-flux membrane where transmembrane water movement carries middle molecules across — convection doing what four hours of diffusion could not. The second patient is overfilled with 4 kg of salt and water; the same high-flux membrane, driven purely by transmembrane pressure, ultrafiltrates the excess while solute drag rides along. The third demonstrates the third mechanism: after an hour the dialyser's hollow fibres are visibly creamed with protein — adsorbed — and the urea clearance measured across the dialyser has fallen, which is one reason adequacy is audited on the patient's blood, not the machine's claims. What no modality in that unit touches meaningfully is the protein-bound fraction; those molecules stay hitched to albumin and pass by the membrane, which is why "the patient is well dialysed but still itches" is not a contradiction. ## Where students slip The commonest error is equating urea removal with dialysis adequacy in full: Kt/V at 1.3 says small-solute dose is fine, and nothing about beta-2 microglobulin, phosphate in the weeks between dose changes, or protein-bound solutes — an MCQ that pairs "well-dialysed patient with carpal tunnel syndrome" with a normal Kt/V is testing exactly this gap. The second slip is flux versus flow: high flux is a membrane property (Kuf), high blood flow is a circuit property; running a low-flux dialyser at 400 mL/min produces big urea numbers and zero middle-molecule benefit. Third, diffusion moves down a gradient — so the dialysate must always leave the dialyser with a gradient intact, which is why countercurrent flow (blood and dialysate moving in opposite directions) preserves the gradient along the whole fibre length and is worth naming in the viva. ## Frequently asked questions ### Which uraemic toxin causes dialysis-related amyloidosis? Beta-2 microglobulin, an 11,800-dalton middle molecule; it deposits in joints and bone after years of low-flux dialysis, causing carpal tunnel syndrome and arthropathy. ### Why are middle molecules poorly removed by diffusion? Their size slows movement across even porous membranes, so removal depends on convection — water movement carrying solute across a high-flux membrane. ### What distinguishes a high-flux from a low-flux dialyser? The ultrafiltration coefficient (Kuf): low-flux membranes pass under about 10 mL/h/mmHg of water, high-flux above roughly 20, allowing convection and middle-molecule clearance. ### Name a protein-bound uraemic toxin and its clinical association. Indoxyl sulphate, over 90 per cent albumin-bound, is linked with uraemic itching, inflammation and cardiovascular disease, and is poorly cleared by standard dialysis. ### What is the advantage of countercurrent flow in a dialyser? Blood and dialysate flow in opposite directions, maintaining the concentration gradient along the entire fibre length and maximising diffusive clearance.